Even if each peptide has independent research support, the combination has not been studied for synergy, antagonism, pharmacokinetic interaction, or safety
While the public advisory committee meetings convened in 2024 resulted in the PCAC voting against inclusion of all previous peptides under review, finding that they posed unacceptable safety risks for compounding, whether the current regulatory and political environment will produce a different outcome at the July meeting remains to be seen
Safety and Handling Considerations Toxicological evaluations of GHK peptide have confirmed safety for cosmetic and research applications at standard concentrations
For example, 0.25 mg is the same as 250 mcg
Genetics of psoriasis in Iceland: evidence for linkage of subphenotypes to distinct loci
Tyna Moore, a naturopathic physician and chiropractor whos spent decades in regenerative medicine and metabolic health